Delivery Order SPE2DB22D2206-SPE2DB25FHB58
Award Date
5/21/25
Potential Completion Date
5/22/25
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,839.70 firm fixed-price delivery order is for the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,703.26 firm fixed-price delivery order is for the supply of CAPLYTA 21 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of May 14, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,110.70 firm-fixed-price delivery order covers the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product, through December 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,067.73 Firm Fixed Price delivery order contract is for the supply of CAPLYTA 42 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award is a delivery order valued at $25,563.63 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through March 19, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $8,573.37 for the provision of CAPLYTA 21 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of November 15, 2023 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,314.77 firm fixed-price delivery order contract is for the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract has a period of performance through November 26, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of CAPLYTA 42 MG CAPSULE 30S medical products. The $14,189.99 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 28, 2024. The contract is a delivery order and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,171.22, is a delivery order for the provision of CAPLYTA 21 MG CAPSULE 30S. The contract is a firm fixed-price agreement with an ultimate completion date of April 14, 2025. This contract is not associated with any set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,701.55, is a Firm Fixed Price Delivery Order for the supply of CAPLYTA 42 MG Capsules. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...